Search hospitals > Nevada > Reno

Center of Hope at Renown Medical Center

Claim this profile
Reno, Nevada 89502
Global Leader in Ovarian Cancer
Global Leader in Fallopian Tube Cancer
Conducts research for Peritoneal Cancer
Conducts research for Uterine Cancer
Conducts research for Ovarian Carcinoma
39 reported clinical trials
1 medical researcher
Photo of Center of Hope at Renown Medical Center in RenoPhoto of Center of Hope at Renown Medical Center in RenoPhoto of Center of Hope at Renown Medical Center in Reno

Summary

Center of Hope at Renown Medical Center is a medical facility located in Reno, Nevada. This center is recognized for care of Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer, Uterine Cancer, Ovarian Carcinoma and other specialties. Center of Hope at Renown Medical Center is involved with conducting 39 clinical trials across 74 conditions. There are 1 research doctors associated with this hospital, such as Peter Lim.

Area of expertise

1Ovarian Cancer
Global Leader
Center of Hope at Renown Medical Center has run 26 trials for Ovarian Cancer. Some of their research focus areas include:
FRα positive
Stage III
Stage IV
2Fallopian Tube Cancer
Global Leader
Center of Hope at Renown Medical Center has run 18 trials for Fallopian Tube Cancer. Some of their research focus areas include:
FRα positive
Stage III
Stage IV

Top PIs

Clinical Trials running at Center of Hope at Renown Medical Center

Ovarian Cancer
Fallopian Tube Cancer
Endometrial Cancer
Cervical Cancer
Mixed Mullerian Tumor
Peritoneal Cancer
Cancer
Peritoneal Neoplasm
Uterine Carcinoma
Serous Cystadenocarcinoma
Image of trial facility.

Olvi-Vec + Chemotherapy

for Ovarian Cancer

The OnPrime study is a multi-center, randomized open-label phase 3 study evaluating the safety and efficacy of Olvi-Vec followed by platinum-doublet chemotherapy and bevacizumab compared to the Active Comparator Arm with Physician's Choice of chemotherapy and bevacizumab in women diagnosed with platinum-resistant/refractory ovarian cancer (includes fallopian tube cancer and primary peritoneal cancer). This Phase III trial builds on the efficacy and safety data reported in the previous Phase II VIRO-15 trial with promising objective response rate and progression-free survival observed in heavily pre-treated patients with platinum-resistant/refractory ovarian cancer. The phase II results also showed that the intra-peritoneal route of delivery was efficient in generating tumor cell killing and immune activation, and led to clinical reversal of platinum-resistance or refractoriness in this difficult-to-treat patient population.
Recruiting2 awards Phase 37 criteria
Image of trial facility.

Rina-S

for Ovarian Cancer

This phase 3 study will be conducted in different countries all over the world. The purpose of this study is to compare how well Rina-S works against platinum-resistant ovarian cancer compared to chemotherapy drugs that are already approved and used for platinum-resistant ovarian cancer. Treatment in this study could be Rina-S or it could be 1 of 4 indicated chemotherapy agents that are considered standard medical care. There is an equal (50:50) chance of getting Rina-S or an approved chemotherapy agent as treatment in this study. No one will know what treatment they are assigned to until the first dose. All participants will receive active drug; no one will be given placebo.
Recruiting2 awards Phase 34 criteria
Image of trial facility.

Mirvetuximab + Bevacizumab

for Ovarian Cancer

GLORIOSA is a Phase 3 multicenter, open label study designed to evaluate the safety and efficacy of mirvetuximab Soravtansine + Bevacizumab as maintenance therapy in participants with platinum-sensitive ovarian, primary peritoneal or fallopian tube cancers with high folate receptor-alpha (FRα) expression.
Recruiting2 awards Phase 3

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Center of Hope at Renown Medical Center?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security